KING OF PRUSSIA, Pa., April 27, 2023 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President and Chief Financial Officer will present at the following conferences:
Tuesday, May 9, 2023, at 2:20pm (PT)/5:20pm (ET) at the Bank of America Securities 2023 Healthcare Conference in Las Vegas, Nevada
Tuesday, May 16, 2023, at 9:30am (ET) at the 2023 RBC Capital Markets Global Healthcare Conference in New York, New York
Live audio webcasts of the presentations will be available on the Company's website (www.uhs.com). For those unable to listen to the live webcast, replays of the presentations will be available on the Company's website for 90 days following the conferences.
Universal Health Services, Inc. ("UHS") is one of the nation's largest providers of hospital and healthcare services. Through its subsidiaries, UHS operates acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points located throughout the United States, Puerto Rico and the United Kingdom.
| Last Trade: | US$223.87 |
| Daily Change: | 1.27 0.57 |
| Daily Volume: | 981,670 |
| Market Cap: | US$12.360B |
October 29, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
